We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$2.87B
AUM Growth
+$220M
Cap. Flow
+$109M
Cap. Flow %
3.81%
Top 10 Hldgs %
16.44%
Holding
1,403
New
110
Increased
744
Reduced
424
Closed
66

Sector Composition

Rank Sector Weight
1 Energy 6.47%
2 Technology 4.94%
3 Financials 4.79%
4 Healthcare 4.42%
5 Industrials 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCI
1326
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$12K ﹤0.01%
1
ERN
1327
DELISTED
Erin Energy Corp
ERN
$9K ﹤0.01%
2,029
KIPS
1328
DELISTED
KIPS BAY MEDICAL INC
KIPS
$9K ﹤0.01%
20,000
STAB
1329
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$7K ﹤0.01%
750
QBC
1330
DELISTED
CUBIC ENERGY INC
QBC
$5K ﹤0.01%
30,000
AMBA icon
1331
Ambarella
AMBA
$3.6B
-25,941
Closed -$693K
AROW icon
1332
Arrow Financial
AROW
$644M
-14,254
Closed -$286K
BHP icon
1333
BHP
BHP
$230B
-4,219
Closed -$242K
BIT icon
1334
BlackRock Multi-Sector Income Trust
BIT
$704M
-11,084
Closed -$197K
BRW
1335
Saba Capital Income & Opportunities Fund
BRW
$340M
-47,368
Closed -$549K
CODI icon
1336
Compass Diversified
CODI
$834M
-19,118
Closed -$362K
CRF
1337
Cornerstone Total Return Fund
CRF
$1.17B
-2,979
Closed -$69K
DPZ icon
1338
Domino's
DPZ
$11.5B
-8,075
Closed -$622K
EWL icon
1339
iShares MSCI Switzerland ETF
EWL
$2.24B
-6,252
Closed -$215K
FCEL icon
1340
FuelCell Energy
FCEL
$1.59B
-4
Closed -$47K
GDO
1341
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.3M
-13,024
Closed -$237K
GEOS icon
1342
Geospace Technologies
GEOS
$72.8M
-8,519
Closed -$564K
HDGE icon
1343
AdvisorShares Ranger Equity Bear ETF
HDGE
$53.1M
-1,132
Closed -$144K
HHS icon
1344
Harte-Hanks
HHS
$18.5M
-2,019
Closed -$178K
IEP icon
1345
Icahn Enterprises
IEP
$5.28B
-2,130
Closed -$219K
IGD
1346
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$522M
-46,731
Closed -$430K
INO icon
1347
Inovio Pharmaceuticals
INO
$76.1M
-1,819
Closed -$291K
ITB icon
1348
iShares US Home Construction ETF
ITB
$2.35B
-10,630
Closed -$257K
KBWD icon
1349
Invesco KBW High Dividend Yield Financial ETF
KBWD
$423M
-8,979
Closed -$229K
LNN icon
1350
Lindsay Corp
LNN
$1.17B
-2,569
Closed -$227K

Similar funds

Cambridge Investment Research Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Cambridge Investment Research Advisors held 1,403 positions worth $2.87B, up 8.3% from $2.65B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Cambridge Investment Research Advisors deployed $109M of net new capital in Q2 2014, opening 110 new positions and adding to 744 existing holdings. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 32,381 shares worth $3.32M.

By sector, the portfolio is most concentrated in Energy at 6.5% of assets, up from 6.2% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $13.3M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2014 buy was iShares 0-5 Year TIPS Bond ETF: 32,381 shares worth $3.32M.
  • Cambridge Investment Research Advisors added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2014, an estimated $13.6M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2014 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $13.3M.
  • Cambridge Investment Research Advisors fully exited Invesco Chinese Yuan Dim Sum Bond ETF in Q2 2014, selling an estimated $1.71M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 16% of its $2.87B portfolio in Q2 2014.
  • Cambridge Investment Research Advisors opened 110 new positions and closed 66 in Q2 2014.
  • Cambridge Investment Research Advisors's portfolio value rose 8.3% quarter-over-quarter to $2.87B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2014, filed 25 Jul 2014.